Everlab Secures $65 Million in Latest Series A Funding Round

Everlab secured $65 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Everlab Raises $65 million in Funding

Everlab Raises AU$65m Series A to Make World-Class Preventative Healthcare Something Everyone Can Access.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Everlab operates in Healthcare & Life Sciences. Everlab's Series A round shows investors are still backing digital health platforms with real scale narratives. At $65M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Make World-Class Preventative Healthcare Something Everyone Can Access.

Looking Ahead

Everlab Raises AU$65m Series A to Make World-Class Preventative Healthcare Something Everyone Can Access

Source reference: original announcement/article.